Xcelthera Secures Patent for Large-Scale Production High Quality Human ES Cell Therapy Products
Xcelthera Inc and its joint research partner San Diego Regenerative Medicine Institute announced today that the USPTO has granted Patent No. 8,716,017 entitled “Technologies, Methods, and Products of Small Molecule-Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells”. - May 08, 2014
Press Releases 1 - 1 of 1